Home > Financial Ratios > LYKA LABS

LYKA LABS
Working Capital/Sales

    Back to All Ratios
LYKA LABS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 8.558.02-4.12-4.15-2.02

What is the latest Working Capital/Sales ratio of LYKA LABS ?

The latest Working Capital/Sales ratio of LYKA LABS is 8.55 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20248.55
Mar20238.02
Mar2022-4.12
Mar2021-4.15
Mar2020-2.02

How is Working Capital/Sales of LYKA LABS Trending?

Years Working Capital/Sales % Change
Mar2024 8.55
6.61
Mar2023 8.02
Positive
Mar2022 -4.12
Negative
Mar2021 -4.15
Negative
Mar2020 -2.02 -

Other Financial Ratios of LYKA LABS


Compare Working Capital/Sales ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹415.4 Cr -2.6% 8.8% 10.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,076.0 Cr 0.3% -4.9% 15.8% Stock Analytics
DIVIS LABORATORIES ₹173,924.0 Cr 0.2% 10% 53.5% Stock Analytics
CIPLA ₹121,456.0 Cr 2.3% 1.1% 2.6% Stock Analytics
DR REDDYS LABORATORIES ₹110,197.0 Cr 5.7% 15% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,761.0 Cr 0.8% -0.9% 17.4% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

-2.6%

8.8%

10.1%

SENSEX

0.9%

1.8%

11.1%


You may also like the below Video Courses